PQJA:NASDAQPGIM Nasdaq-100 Buffer 12 ETF - January Analysis
Data as of 2026-06-03 - not real-time
$31.75
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The ETF is trading at $31.75, just below the identified resistance of $31.78 and comfortably above the support level of $30.90, with the 20‑day SMA ($31.38) sitting above both the 50‑day ($30.23) and 200‑day ($28.97) averages, underscoring a clear bullish alignment. RSI is elevated at 79.8, signaling an overbought condition, while the MACD histogram has turned slightly negative and the signal line is labeled bearish, hinting at a potential short‑term pullback despite the overall bullish trend. Volume is increasing, which supports the upward momentum, but daily trading volume remains modest (395 shares) relative to its 10‑day average of 4,600, raising a note of caution on liquidity.
Risk metrics paint a nuanced picture: the fund’s beta of 0.64 indicates lower volatility than the broader market, and 30‑day volatility sits at a moderate 5.2%. The maximum drawdown of –6.8% is contained, and the Fear & Greed Index at 92.4 reflects extreme market optimism. With a zero tracking error, no premium/discount, and a reasonable expense ratio of 0.5%, the structural costs are low, yet the concentrated Nasdaq‑100 exposure translates to high sector concentration risk.
Given these dynamics, a short‑term hold is prudent as the price hovers near resistance and RSI suggests limited upside in the immediate horizon. For the medium term, the bullish SMA crossover, low beta, and increasing volume support a buy stance, while the defined‑outcome buffer offers downside protection that aligns with a longer‑term hold perspective.
Risk metrics paint a nuanced picture: the fund’s beta of 0.64 indicates lower volatility than the broader market, and 30‑day volatility sits at a moderate 5.2%. The maximum drawdown of –6.8% is contained, and the Fear & Greed Index at 92.4 reflects extreme market optimism. With a zero tracking error, no premium/discount, and a reasonable expense ratio of 0.5%, the structural costs are low, yet the concentrated Nasdaq‑100 exposure translates to high sector concentration risk.
Given these dynamics, a short‑term hold is prudent as the price hovers near resistance and RSI suggests limited upside in the immediate horizon. For the medium term, the bullish SMA crossover, low beta, and increasing volume support a buy stance, while the defined‑outcome buffer offers downside protection that aligns with a longer‑term hold perspective.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI in overbought territory
- Price near resistance level
- Modest daily trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Bullish SMA alignment across 20, 50, and 200 days
- Low beta indicating reduced market volatility
- Increasing volume trend supporting momentum
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Defined‑outcome buffer protecting against downside
- Controlled max drawdown and moderate volatility
- Absence of tracking error and low expense ratio
Key Metrics & Analysis
Fund Metrics
Expense Ratio0.50%
AUM$25.1M
Inception Date2024-12-27
Avg Daily Volume4,600
Premium/Discount0.00%
Tracking Error0.00%
Technical Analysis
TrendBullish
RSI79.8
Support$30.90
Resistance$31.78
MA 20$31.38
MA 50$30.23
MA 200$28.97
MACDBearish
VolumeIncreasing
Fear & Greed Index92.41
Risk Assessment
Beta0.64
Volatility5.24%
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.